Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a neuroactive steroid to treat depressed mood in people living with HIV and is currently recruiting. The study aims to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational neuroactive steroid

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Anxiety Depression | Phase 2 | Status: RECRUITING